The role of plasma exchange in hyperbilirubinemia from a different perspective
Abstract
Objective: In this retrospective study, we aimed to present our experience of managing hyperbilirubinemia.
Method: Twenty three patients with hyperbilirubinemia who received apharesis treatment between 2006 and 2017 at the apheresis unit of Cumhuriyet University School of Medicine were included in the study. Records of the patients were evaluated retrospectively and the following data were collected: patient’s age, sex, presenting symptoms, number of plasma exchange, adjuvant treatment modalities, use of replacement fluid, treatment outcomes, and plasma exchange complications.
Results: The median age of the patients was 57 years (range; 18-82). The median number of plasma exchange was 5,5 (range; 1-25). Fresh frozen plasma was the only replacement fluid used. There was significant statistical differences between pre- and post-plasma exchange bilirubine levels (p<0.05). Toxic hepatitis was the most common cause of hyperbilirubinemia in our patient population. In addition to plasma exchange, patients were treated with proper treatment of the underlying condition. We observed allergic reactions 2 (8.69%) patients and hypotension in 3 (13%) patients as complications
Conclusions: Plasma exchange is a safe method for the elimination of bilirubin. However, diminishing hyperbilirubinemia with plasma exchange together with the proper treatment of the underlying condition should be the primary goal in management.
Keywords
Kaynakça
- References1) Duan ZJ, Li LL, Ju J, et al. Treatment of hyperbilirubinemia with blood purification in China. World J Gastroenterol 2006; 12:7467-71.References2) Liu HB, Chen W, Dou KF, et al. Application of hemodialysis with plasma-based dialysate in patients with hyperbilirubinemia. J Nephrol Dialy Transplant 2004; 13:539- 43.References3) Nakae H, Yonekawa T, Narita K, et al. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol 2001; 109:65-72.References4) Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, et al. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J Hepatol. 2016 Jan;64(1):69-78.References5) Shapiro SM, Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005; 25:54-9.References6) Altıntaş E, Tombak A, Tellioğlu B, Ciddi hiperbilirubinemi nedenleri, tanı ve sağaltımı. Akademik gastroenteroloji dergisi 2010; 9(1):2-7.References7) Jin F, Cao M, Bai Y, et al. Therapeutic effects of plasma exchange for the treatment of 39 patients with acute fatty liver of pregnancy. Discovery Medicine 2012; 13:369-73.References8) Li M, Wang Z, Wang Y, Du C, Li S, Shi Z, et al. Part of plasmapheresis with plasma filtration adsorption combined with continuous hemodiafiltration in the treatment of severe acute liver failure. Exp Ther Med. 2016 Oct;12(4):2582-2584.References9) Nakamura T, Ushiyama C, Suzuki S, et al. Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis. Blood Purif 2000; 18:50-4.References10) De Silvestro G, Marson P, Brandolese R, et al. A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure. Int J Artif Organs 2000; 23:454-61.References11) Ch'ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51(6):876-80.References12) Ho DW, Fan ST, To J, et al. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut 2002; 50:869-76.References13) Shinozaki K, Oda S, Abe R, et al. Blood purification in fulminant hepatic failure. Contrib Nephrol 2010; 166:64-72. References14) Kamada N, Yoneyama K, Togawa Y, et al. Toxic epidermal necrolysis with severe hyperbilirubinemia: complete re-epithelialization after bilirubin reduction therapies. J Dermatol 2010; 37:534-6. References15) Chu YF, Meng M, Zeng J, et al. Effectiveness of combining plasma exchange with continuous hemodiafiltration on acute Fatty liver of pregnancy complicated by multiple organ dysfunction. Artif Organs 2012; 36:530-4.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Hatice Terzi
*
Türkiye
Serdal Korkmaz
Türkiye
Mehmet Şencan
Türkiye
Özlem Yönem
Türkiye
Abdulkerim Yılmaz
Türkiye
Hilmi Ataseven
Türkiye
Yayımlanma Tarihi
28 Mart 2019
Gönderilme Tarihi
2 Eylül 2018
Kabul Tarihi
26 Mart 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 41 Sayı: 1